Nikkiso Co., Ltd. (JP:6376)
:6376
Want to see JP:6376 full AI Analyst Report?
6376 Stock Chart & Stats
¥1577.00
-¥8.00(-0.83%)
At close: 4:00 PM EST
¥1577.00
-¥8.00(-0.83%)
Day’s Range― - ―
52-Week Range¥1,230.00 - ¥4,295.00
Previous CloseN/A
Volume212.80K
Average Volume (3M)185.66K
Market Cap
¥258.25B
Enterprise Value¥330.44B
Total Cash (Recent Filing)¥38.61B
Total Debt (Recent Filing)¥114.85B
Price to Earnings (P/E)19.2
Beta1.02
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.04%
Share Statistics
EPS (TTM)220.41
Shares Outstanding69,175,670
10 Day Avg. Volume215,040
30 Day Avg. Volume185,656
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)0.66
Price to Sales (P/S)0.49
P/FCF Ratio8.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)222.2
Revenue Forecast (FY)¥240.00B
Bulls Say, Bears Say
Bulls Say
Improved ProfitabilityRecent TTM results show a clear step-up in profitability: gross margin rose to ~30% and net margin to ~6.5%, with net income of 14.5B and ~7.2% operating margin. Higher margins improve sustainable operating cash generation and durability of returns from engineered products and services.
Diversified, Service‑anchored ModelNikkiso’s mix of engineered systems, cryogenic technologies and medical devices plus lifecycle after‑sales services creates multiple revenue streams. The installed‑base service revenue is recurring and reduces cyclical sensitivity, supporting steadier long‑term cash flows and customer retention.
Stronger Balance Sheet Vs 2021Leverage has meaningfully moderated since 2021, with debt-to-equity down to ~0.70 and reported ROE improvement to ~9.5% TTM. This stronger capital structure gives more room to fund capex or strategic initiatives and lowers distress risk versus prior years.
Bears Say
Weak Cash ConversionCash generation is the weakest area: free cash flow plunged ~85% to 1.85B and covers only ~24% of net income in the latest TTM. Poor cash conversion strains the firm’s ability to self-fund investment, service capital needs, or accelerate deleveraging without external financing.
Meaningful Remaining LeverageAlthough improved, leverage remains material for an industrial manufacturer: 114.8B of debt and D/E ~0.70. That leaves less cushion if cash flows deteriorate or capex needs rise, increasing refinancing and interest‑rate exposure during slower demand periods.
Inconsistent Multi‑year EarningsThe company’s earnings history is uneven, with very weak net margins in 2021 and a softer 2024 before the recent rebound. This cyclicality or execution variability undermines predictability of future margins and complicates medium‑term planning and capital allocation.
Nikkiso Co., Ltd. News
6376 FAQ
What was Nikkiso Co., Ltd.’s price range in the past 12 months?
Nikkiso Co., Ltd. lowest stock price was ¥1230.00 and its highest was ¥4295.00 in the past 12 months.
What is Nikkiso Co., Ltd.’s market cap?
Nikkiso Co., Ltd.’s market cap is ¥258.25B.
When is Nikkiso Co., Ltd.’s upcoming earnings report date?
Nikkiso Co., Ltd.’s upcoming earnings report date is Aug 17, 2026 which is in 50 days.
How were Nikkiso Co., Ltd.’s earnings last quarter?
Nikkiso Co., Ltd. released its earnings results on May 15, 2026. The company reported ¥48.36 earnings per share for the quarter, beating the consensus estimate of N/A by ¥48.36.
Is Nikkiso Co., Ltd. overvalued?
According to Wall Street analysts Nikkiso Co., Ltd.’s price is currently Overvalued.
Does Nikkiso Co., Ltd. pay dividends?
Nikkiso Co., Ltd. pays a Semiannually dividend of ¥25 which represents an annual dividend yield of 2.04%. See more information on Nikkiso Co., Ltd. dividends here
What is Nikkiso Co., Ltd.’s EPS estimate?
Nikkiso Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nikkiso Co., Ltd. have?
Nikkiso Co., Ltd. has 69,175,670 shares outstanding.
What happened to Nikkiso Co., Ltd.’s price movement after its last earnings report?
Nikkiso Co., Ltd. reported an EPS of ¥48.36 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 8.538%.
Which hedge fund is a major shareholder of Nikkiso Co., Ltd.?
Currently, no hedge funds are holding shares in JP:6376
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nikkiso Co., Ltd.
Nikkiso Co., Ltd. is a global enterprise that operates across a diverse range of sectors, including industrial solutions, aerospace components, precision instruments, deep ultraviolet (DUV) LED technology, and medical devices. The company's operations are primarily organized into two main divisions: the Industrial Business segment and the Medical Business segment. The Industrial Business segment focuses on the development, production, sales, and maintenance of specialized industrial pumps, such as leak-proof pumps, accurate metering pumps, and cryogenic pumps vital for liquefied natural gas (LNG) transfer. This division also provides advanced water conditioning systems for thermal and nuclear power plants, along with integrated system products that combine water treatment capabilities with automation and other sophisticated functions. Furthermore, it supplies warm laminating systems, various electronic component manufacturing equipment, carbon fiber reinforced plastic (CFRP) products designed for civilian aircraft, and deep ultraviolet LEDs and their associated technologies. Within the Medical Business segment, Nikkiso is engaged in the manufacturing, distribution, and servicing of products and medical supplies crucial for kidney-related therapies, including hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Its key offerings encompass comprehensive dialysis systems, dialyzers, blood tubing lines, and powdered dialysate. This segment also produces blood glucose monitoring devices, air purification units, innovative ozone-water hand-washing systems, and microwave-based surgical instruments. Founded in 1950 as Nippon Kikai Keiso Kaisha Ltd., the company officially changed its name to Nikkiso Co., Ltd. in November 1968. Its corporate headquarters are located in Tokyo, Japan.
Technical Analysis
Kitz
―
Iwaki Co. Ltd.
―
Torishima Pump Mfg.Co., Ltd.
―
ANEST IWATA Corp.
―
Miyairi Valve Mfg.Co., Ltd.
―
Options Prices
Currently, No data available
---